Maximizing and maintaining function for persons with Alzheimer's disease using non-pharmacologic methods

被引:0
|
作者
Warchol, K
机构
关键词
D O I
暂无
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
引用
收藏
页码:292 / 292
页数:1
相关论文
共 50 条
  • [41] Efficacy of nicotineless non-pharmacologic alternative tool for smoking cessation program using varenicline
    Kasamatsu, Yu
    Yoshinoya, K.
    Kadoya, M.
    Kasamatsu, Y.
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [42] DECREASING PEDIATRIC PRE-PROCEDURE ANXIETY USING A NON-PHARMACOLOGIC APPROACH.
    Steele, Rachel
    Gatrell, Andrea
    Brophy, Lynne
    ONCOLOGY NURSING FORUM, 2017, 44 (02)
  • [43] Subcortical infarcts, Alzheimer's disease pathology, and memory function in older persons
    Schneider, Julie A.
    Boyle, Patricia A.
    Arvanitakis, Zoe
    Bienias, Julia L.
    Bennett, David A.
    ANNALS OF NEUROLOGY, 2007, 62 (01) : 59 - 66
  • [44] A Non-pharmacologic Approach to Pain Management Using Aromatherapy: A Train-the-Trainer Approach
    Boyce, Victoria J.
    Natschke, Mary
    PAIN MANAGEMENT NURSING, 2016, 17 (02) : 98 - 99
  • [45] EFFICACY OF DIFFERENT EXERCISE PROGRAMS ON COGNITIVE FUNCTION IN PERSONS WITH ALZHEIMER'S DISEASE
    Eichberg, S.
    GERONTOLOGIST, 2009, 49 : 446 - 446
  • [46] Evaluation of non-pharmacologic intervention for Parkinson patient using gait analysis: A case study
    Ganason, R.
    Joseph, S.
    Wilson, B. D.
    Selvarajah, V.
    IMPACT OF TECHNOLOGY ON SPORTS II, 2008, : 59 - 63
  • [47] Parvalbumin neuroplasticity compensates for somatostatin impairment, maintaining cognitive function in Alzheimer’s disease
    Christopher Daniel Morrone
    Aaron Yenhsin Lai
    Jossana Bishay
    Mary Elizabeth Hill
    JoAnne McLaurin
    Translational Neurodegeneration, 11
  • [48] Parvalbumin neuroplasticity compensates for somatostatin impairment, maintaining cognitive function in Alzheimer's disease
    Morrone, Christopher Daniel
    Lai, Aaron Yenhsin
    Bishay, Jossana
    Hill, Mary Elizabeth
    McLaurin, JoAnne
    TRANSLATIONAL NEURODEGENERATION, 2022, 11 (01)
  • [49] Pharmacologic approaches to cognitive deficits in Alzheimer's disease
    Peskind, ER
    JOURNAL OF CLINICAL PSYCHIATRY, 1998, 59 : 22 - 27
  • [50] Alzheimer's disease: Clinical features and pharmacologic management
    Franks, AS
    Rawls, WN
    AMERICAN JOURNAL OF MANAGED CARE, 1998, 4 (04): : 595 - 604